Care Navigation for Methamphetamine Addiction
(BEATMeth Trial)
Trial Summary
What is the purpose of this trial?
The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Care Navigation for Methamphetamine Addiction is an effective treatment?
The available research shows that coordinating care for substance use disorders, like methamphetamine addiction, can lead to better health outcomes. For example, one study found that integrating behavioral health staff within primary care teams helps improve care transitions, which is important for effective treatment. Another study highlighted that people with substance use disorders, including methamphetamine users, benefit from accessing professional support services, especially when they face more severe use patterns and related harms. These findings suggest that Care Navigation, which involves coordinating different types of support, can be effective in helping people with methamphetamine addiction.12345
What safety data exists for Care Navigation in methamphetamine addiction treatment?
The provided research does not directly address safety data for Care Navigation or similar interventions like Care Coordination, Social Prescribing, or Active Signposting specifically for methamphetamine addiction. The studies focus on opioid use disorder treatments, medication-assisted treatments, and care coordination for substance use disorders in general, but do not provide specific safety data for the treatment of methamphetamine addiction using Care Navigation.24567
Is Care Navigation a promising treatment for methamphetamine addiction?
Yes, Care Navigation is a promising treatment for methamphetamine addiction. It helps people connect with health and support services, which can improve their chances of starting and staying in treatment. This approach is especially helpful for those who face challenges in accessing healthcare, as it provides guidance and support to meet their needs.1891011
Research Team
Alia A Al-Tayyib, PhD
Principal Investigator
Denver Health
Eligibility Criteria
This trial is for adults over 18 who've had a meth-related health issue at Denver Health and haven't received substance use treatment there in the last 90 days. It's not for those planning to enter substance treatment soon, unable to interview in English, impaired, or under involuntary psychiatric/substance treatment orders.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Care Navigation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Denver Health and Hospital Authority
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator